BMO Capital Lift PT on Regeneron (REGN) 33% Following New EYLEA Data
Tweet Send to a Friend
BMO Capital raises its price target on Regeneron (Nasdaq: REGN) from $283 to $377 following an earlier announcement that EYLEA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
